Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid in High Risk Localized Breast Cancer
NCT00072020Phase 3Unknown
- Sponsor
- University of Sheffield
- Start
- Aug 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of zoledronic acid in breast cancer, sponsored by University of Sheffield. Status: unknown.
02
Drugs
zoledronic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00072020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00072020.